Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
94 participants
INTERVENTIONAL
2016-02-29
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia
NCT00080184
Biofeedback Training, Efficacy Evaluation of Fibromyalgia Treatment, a Pilot Study
NCT04121832
Management of Chronic Pain
NCT04865263
Developing Biomarkers for Fibromyalgia
NCT00932061
A Randomized Controlled Trial to Evaluate the Effectiveness of Electromyography (EMG)-Biofeedback in Patients With Fibromyalgia
NCT02186756
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biofeedback Training 1
Participants will receive brief training in relaxation and biofeedback to develop basic skills in relaxation/arousal reduction. Then they will receive instructions to relax and reduce arousal as they view graphical arousal feedback. Electric stimulations will be delivered throughout the biofeedback to provide pain relief when relaxation is achieved.
Biofeedback Training
Participants will received biofeedback training to reduce arousal and pain
Biofeedback Training 2
Participants will receive brief training in relaxation and biofeedback to develop basic skills in relaxation/arousal reduction. Then they will receive instructions to relax and reduce arousal as they view graphical arousal feedback. Electric stimulations will be delivered throughout the biofeedback to provide a painful context in which to practice relaxing.
Biofeedback Training
Participants will received biofeedback training to reduce arousal and pain
Biofeedback Training 3
Participants will receive brief training in relaxation and biofeedback to develop basic skills in relaxation/arousal reduction. Then they will receive instructions to relax and reduce arousal as they view graphical arousal feedback.
Biofeedback Training
Participants will received biofeedback training to reduce arousal and pain
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biofeedback Training
Participants will received biofeedback training to reduce arousal and pain
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* history of serious cardiovascular, neuroendocrine, or neurological disorders
* hypertension (due to a relationship between blood pressure and pain);5 4) history of chronic pain
* current opioid, antidepressant, or anxiolytic medication use
* psychosis or apparent cognitive impairment
* body mass index\>35 (due to difficulty eliciting an NFR in persons with high adiposity)
* inability to understand and read English (questionnaires and consent form are in English)
* recent use of an over-the-counter pain medication (within the last 24 hours) or narcotic medication (within the last two weeks)
* history of panic attacks. No one will be excluded based on ethnic, racial, or gender characteristics.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Tulsa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie Rhudy
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamie L Rhudy, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Tulsa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Tulsa
Tulsa, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TU1560
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.